DYSPORT DIRECT Trademark

Trademark Overview


On Monday, December 16, 2024, a trademark application was filed for DYSPORT DIRECT with the United States Patent and Trademark Office. The USPTO has given the DYSPORT DIRECT trademark a serial number of 98904630. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 30, 2025. This trademark is owned by IPSEN BIOPHARM LIMITED. The DYSPORT DIRECT trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Retail pharmacy services; online retail store services featuring pharmaceutical products; online retail pharmacy services for the ordering, purchase, and delivery of pharmaceutical products; pharmaceutical services, namely, processing prescription orders

Providing information relating to therapeutic properties of pharmaceuticals

Platform as a service (PAAS) featuring computer software for permitting users to identify, request and receive pharmaceutical products
dysport direct

General Information


Serial Number98904630
Word MarkDYSPORT DIRECT
Filing DateMonday, December 16, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, June 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 22, 2025

Trademark Statements


Goods and ServicesRetail pharmacy services; online retail store services featuring pharmaceutical products; online retail pharmacy services for the ordering, purchase, and delivery of pharmaceutical products; pharmaceutical services, namely, processing prescription orders
Goods and ServicesProviding information relating to therapeutic properties of pharmaceuticals
NOT AVAILABLE"DIRECT"
Goods and ServicesPlatform as a service (PAAS) featuring computer software for permitting users to identify, request and receive pharmaceutical products

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 16, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 16, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIPSEN BIOPHARM LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWREXHAM LL139UF
GB

Trademark Events


Event DateEvent Description
Monday, December 16, 2024NEW APPLICATION ENTERED
Sunday, April 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 3, 2025ASSIGNED TO EXAMINER
Thursday, June 12, 2025NON-FINAL ACTION WRITTEN
Thursday, June 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 12, 2025NON-FINAL ACTION E-MAILED
Friday, June 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 16, 2025EXAMINER'S AMENDMENT ENTERED
Monday, June 16, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 16, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, June 16, 2025EXAMINERS AMENDMENT E-MAILED